Minutes of Institutional Review Board (IRB) Meetings: Guidance for Institutions and IRBs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 25, 2017
November 14, 2024
4b56f900-1718-406d-8e07-7ef1b122f0f3
Related Documents
Use of Electronic Informed Consent in Clinical Investigations – Questions and Answers: Guidance for Institutional Review Boards, Investigators, and Sponsors
Guidance DocumentDecember 15, 2016Center for Drug Evaluation and Research
Civil Money Penalties Relating to the ClinicalTrialsgov Data Bank: Guidance for Responsible Parties, Submitters of Certain Applications and Submissions to FDA, and FDA Staff
Guidance DocumentAugust 14, 2020Office of the Commissioner
Institutional Review Board (IRB) Written Procedures: Guidance for Institutions and IRBs
Guidance DocumentFebruary 5, 2025Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.